Atlas Trials

Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer Patients

Clinical trial NCT02707159 · COMPLETED

Trial details

NCT number
NCT02707159
Sponsor
Helse Stavanger HF
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Pancreatic Cancer
Start date
2014-11-01
Primary completion
2017-10-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.